FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic

The COVID-19 pandemic disrupted nearly all industries in 2020, with the pharmaceutical industry being no exception. For the pharmaceutical industry, the lack of face-to-face meetings caused the U.S. Food and Drug Administration (FDA) to implement regulatory workarounds to stay on top of drug and biologics approvals.